{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:21:01Z","timestamp":1780086061449,"version":"3.54.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82302642"],"award-info":[{"award-number":["82302642"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32070395"],"award-info":[{"award-number":["32070395"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103055"],"award-info":[{"award-number":["82103055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Key Science and Technology Research Project of Henan Province of China","award":["242102311166"],"award-info":[{"award-number":["242102311166"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93695-x","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:19:08Z","timestamp":1742397548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive systems biology analysis reveals splicing factor contributions to cutaneous melanoma progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Shuting","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liucun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"9919","key":"93695_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont, A. M., Spatz, A. & Robert, C. Cutaneous melanoma. Lancet 383(9919), 816 (2014).","journal-title":"Lancet"},{"issue":"5","key":"93695_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 158(5), 495 (2022).","journal-title":"JAMA Dermatol."},{"issue":"21","key":"93695_CR3","doi-asserted-by":"publisher","first-page":"15881","DOI":"10.3390\/ijms242115881","volume":"24","author":"LM Gosman","year":"2023","unstructured":"Gosman, L. M., \u021a\u0103poi, D. A. & Costache, M. Cutaneous melanoma: A review of multifactorial pathogenesis, immunohistochemistry, and emerging biomarkers for early detection and management. Int. J. Mol. Sci. 24(21), 15881 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"10400","key":"93695_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long, G. V. et al. Cutaneous melanoma. Lancet 402(10400), 485 (2023).","journal-title":"Lancet"},{"issue":"11","key":"93695_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2022.24888","volume":"329","author":"JY Wang","year":"2023","unstructured":"Wang, J. Y., Wang, E. B. & Swetter, S. M. What is melanoma?. Jama 329(11), 948 (2023).","journal-title":"Jama"},{"issue":"12","key":"93695_CR6","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.3390\/ijms23126388","volume":"23","author":"A Villani","year":"2022","unstructured":"Villani, A. et al. The treatment of advanced melanoma: Therapeutic update. Int. J. Mol. Sci. 23(12), 6388 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"93695_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley, R. K. & Anczuk\u00f3w, O. RNA splicing dysregulation and the hallmarks of cancer. Nat. Rev. Cancer 23(3), 135 (2023).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"93695_CR8","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/ijms21051551","volume":"21","author":"T Takeiwa","year":"2020","unstructured":"Takeiwa, T. et al. Roles of splicing factors in hormone-related cancer progression. Int. J. Mol. Sci. 21(5), 1551 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"93695_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.canlet.2020.11.043","volume":"501","author":"JX Du","year":"2021","unstructured":"Du, J. X. et al. Splicing factors: Insights into their regulatory network in alternative splicing in cancer. Cancer Lett. 501, 83 (2021).","journal-title":"Cancer Lett."},{"issue":"9","key":"93695_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1261\/rna.057919.116","volume":"22","author":"O Anczuk\u00f3w","year":"2016","unstructured":"Anczuk\u00f3w, O. & Krainer, A. R. Splicing-factor alterations in cancers. RNA 22(9), 1285 (2016).","journal-title":"RNA"},{"issue":"6","key":"93695_CR11","first-page":"643","volume":"61","author":"A Tanaka","year":"2020","unstructured":"Tanaka, A. et al. Understanding and therapeutic targeting of aberrant mrna splicing mechanisms in oncogenesis. Rinsho Ketsueki 61(6), 643 (2020).","journal-title":"Rinsho Ketsueki"},{"issue":"8","key":"93695_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119841","volume":"1871","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Srsf3 suppresses rcc tumorigenesis and progression via regulating sp4 alternative splicing. Biochim. Biophys. Acta 1871(8), 119841 (2024).","journal-title":"Biochim. Biophys. Acta"},{"key":"93695_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216124","volume":"560","author":"L Deng","year":"2023","unstructured":"Deng, L. et al. Myc-driven u2surp regulates alternative splicing of sat1 to promote triple-negative breast cancer progression. Cancer Lett. 560, 216124 (2023).","journal-title":"Cancer Lett."},{"issue":"1","key":"93695_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12026-024-09589-z","volume":"73","author":"X Zheng","year":"2025","unstructured":"Zheng, X. et al. Integrative bioinformatics and experimental analyses identify u2surp as a novel lactylation-related prognostic signature in esophageal carcinoma. Immunol. Res. 73(1), 45 (2025).","journal-title":"Immunol. Res."},{"key":"93695_CR15","doi-asserted-by":"publisher","first-page":"e13741","DOI":"10.1111\/cpr.13741","volume":"58","author":"T Mei\u00dfgeier","year":"2024","unstructured":"Mei\u00dfgeier, T. et al. Splicing control by phf5a is crucial for melanoma cell survival. Cell Prolif. 58, e13741 (2024).","journal-title":"Cell Prolif."},{"issue":"1","key":"93695_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-019-00895-0","volume":"78","author":"C Jin","year":"2020","unstructured":"Jin, C. et al. Circmyc regulates glycolysis and cell proliferation in melanoma. Cell Biochem. Biophys. 78(1), 77 (2020).","journal-title":"Cell Biochem. Biophys."},{"issue":"38","key":"93695_CR17","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/onc.2016.67","volume":"35","author":"P Zhang","year":"2016","unstructured":"Zhang, P. et al. Cd82 suppresses cd44 alternative splicing-dependent melanoma metastasis by mediating u2af2 ubiquitination and degradation. Oncogene 35(38), 5056 (2016).","journal-title":"Oncogene"},{"issue":"4","key":"93695_CR18","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1002\/cam4.5174","volume":"12","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma. Cancer Med. 12(4), 4895 (2023).","journal-title":"Cancer Med."},{"issue":"21","key":"93695_CR19","doi-asserted-by":"publisher","first-page":"12667","DOI":"10.1111\/jcmm.15835","volume":"24","author":"H Feng","year":"2020","unstructured":"Feng, H. et al. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression. J. Cell Mol. Med. 24(21), 12667 (2020).","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"93695_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13048-021-00866-1","volume":"14","author":"D Zhang","year":"2021","unstructured":"Zhang, D. et al. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing. J. Ovarian Res. 14(1), 120 (2021).","journal-title":"J. Ovarian Res."},{"key":"93695_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2023.104340","volume":"140","author":"O Ben-Assuli","year":"2023","unstructured":"Ben-Assuli, O. et al. Utilizing shared frailty with the cox proportional hazards regression: Post discharge survival analysis of chf patients. J. Biomed. Inform. 140, 104340 (2023).","journal-title":"J. Biomed. Inform."},{"issue":"18","key":"93695_CR22","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/jcmm.17849","volume":"27","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Comprehensively analysis of splicing factors to construct prognosis prediction classifier in prostate cancer. J. Cell Mol. Med. 27(18), 2684 (2023).","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"93695_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/mc.23549","volume":"62","author":"R Zhu","year":"2023","unstructured":"Zhu, R. et al. A systems biology-based approach to screen key splicing factors in hepatocellular carcinoma. Mol. Carcinog. 62(8), 1107 (2023).","journal-title":"Mol. Carcinog."},{"key":"93695_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12977-015-0182-4","volume":"12","author":"A Erazo","year":"2015","unstructured":"Erazo, A. & Goff, S. P. Nuclear matrix protein matrin 3 is a regulator of zap-mediated retroviral restriction. Retrovirology 12, 57 (2015).","journal-title":"Retrovirology"},{"key":"93695_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.794646","volume":"8","author":"A Salem","year":"2021","unstructured":"Salem, A. et al. Matrin3: Disorder and als pathogenesis. Front. Mol. Biosci. 8, 794646 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"93695_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3389\/fonc.2019.01538","volume":"9","author":"X Meng","year":"2019","unstructured":"Meng, X., Yang, S. & Camp, V. J. A. The interplay between the DNA damage response, RNA processing and extracellular vesicles. Front. Oncol. 9, 1538 (2019).","journal-title":"Front. Oncol."},{"issue":"68","key":"93695_CR27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22496","volume":"8","author":"TMA Abdel-Fatah","year":"2017","unstructured":"Abdel-Fatah, T. M. A. et al. The localization of pre mrna splicing factor prpf38b is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing her2. Oncotarget 8(68), 112245 (2017).","journal-title":"Oncotarget"},{"issue":"4","key":"93695_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1531","volume":"10","author":"WS Lai","year":"2019","unstructured":"Lai, W. S. et al. The tandem zinc finger RNA binding domain of members of the tristetraprolin protein family. Wiley Interdiscip. Rev. RNA 10(4), e1531 (2019).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"3","key":"93695_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.celrep.2018.09.041","volume":"25","author":"A De Maio","year":"2018","unstructured":"De Maio, A. et al. Rbm17 interacts with u2surp and cherp to regulate expression and splicing of RNA-processing proteins. Cell Rep. 25(3), 726 (2018).","journal-title":"Cell Rep."},{"issue":"2","key":"93695_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jdermsci.2020.08.013","volume":"100","author":"H Kuriyama","year":"2020","unstructured":"Kuriyama, H. et al. Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma. J. Dermatol. Sci. 100(2), 110 (2020).","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"93695_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-022-02558-0","volume":"41","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Srsf10 stabilizes cdc25a by triggering exon 6 skipping to promote hepatocarcinogenesis. J. Exp. Clin. Cancer Res. 41(1), 353 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"93695_CR32","doi-asserted-by":"publisher","first-page":"zcab019","DOI":"10.1093\/narcan\/zcab019","volume":"3","author":"M Sohail","year":"2021","unstructured":"Sohail, M. et al. A novel class of inhibitors that target srsf10 and promote p53-mediated cytotoxicity on human colorectal cancer cells. NAR Cancer 3(2), zcab019 (2021).","journal-title":"NAR Cancer"},{"issue":"1","key":"93695_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13046-020-01625-8","volume":"39","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Srsf10 inhibits biogenesis of circ-atxn1 to regulate glioma angiogenesis via mir-526b-3p\/mmp2 pathway. J. Exp. Clin. Cancer Res. 39(1), 121 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"93695_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.21037\/jgo-20-117","volume":"11","author":"Z Zong","year":"2020","unstructured":"Zong, Z. et al. Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer. J. Gastrointest. Oncol. 11(4), 685 (2020).","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"93695_CR35","doi-asserted-by":"publisher","first-page":"10413","DOI":"10.1038\/s41598-021-89778-0","volume":"11","author":"Y Ouyang","year":"2021","unstructured":"Ouyang, Y. et al. Alternative splicing acts as an independent prognosticator in ovarian carcinoma. Sci. Rep. 11(1), 10413 (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"93695_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-021-03612-z","volume":"12","author":"T Huang","year":"2021","unstructured":"Huang, T. et al. Linc00470 accelerates the proliferation and metastasis of melanoma through promoting apex1 expression. Cell Death Dis. 12(5), 410 (2021).","journal-title":"Cell Death Dis."},{"issue":"6","key":"93695_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/15476286.2020.1822636","volume":"18","author":"J An","year":"2021","unstructured":"An, J. et al. Identification of spliceosome components pivotal to breast cancer survival. RNA Biol. 18(6), 833 (2021).","journal-title":"RNA Biol."},{"issue":"3","key":"93695_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay, C., Tanaka, A. & Sakaguchi, S. Tumor-infiltrating regulatory t cells as targets of cancer immunotherapy. Cancer Cell 41(3), 450 (2023).","journal-title":"Cancer Cell"},{"issue":"13","key":"93695_CR39","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1038\/s41388-020-1179-6","volume":"39","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Wdr74 modulates melanoma tumorigenesis and metastasis through the rpl5-mdm2-p53 pathway. Oncogene 39(13), 2741 (2020).","journal-title":"Oncogene"},{"issue":"1","key":"93695_CR40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/13880209.2023.2200787","volume":"61","author":"X Qi","year":"2023","unstructured":"Qi, X. et al. Sanguinarine inhibits melanoma invasion and migration by targeting the fak\/pi3k\/akt\/mtor signalling pathway. Pharm. Biol. 61(1), 696 (2023).","journal-title":"Pharm. Biol."},{"issue":"10151","key":"93695_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf, D. et al. Melanoma. Lancet 392(10151), 971 (2018).","journal-title":"Lancet"},{"issue":"7778","key":"93695_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","volume":"574","author":"D Inoue","year":"2019","unstructured":"Inoue, D. et al. Spliceosomal disruption of the non-canonical baf complex in cancer. Nature 574(7778), 432 (2019).","journal-title":"Nature"},{"issue":"4","key":"93695_CR43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.molcel.2020.10.019","volume":"80","author":"NK Leclair","year":"2020","unstructured":"Leclair, N. K. et al. Poison exon splicing regulates a coordinated network of sr protein expression during differentiation and tumorigenesis. Mol. Cell 80(4), 648 (2020).","journal-title":"Mol. Cell"},{"issue":"7","key":"93695_CR44","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1158\/2159-8290.CD-22-1013","volume":"13","author":"L Wan","year":"2023","unstructured":"Wan, L. et al. Splicing factor srsf1 promotes pancreatitis and krasg12d-mediated pancreatic cancer. Cancer Discov. 13(7), 1678 (2023).","journal-title":"Cancer Discov."},{"issue":"1","key":"93695_CR45","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1038\/s41467-022-34042-w","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Splicing factor bud31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic bcl2l12. Nat. Commun. 13(1), 6246 (2022).","journal-title":"Nat. Commun."},{"issue":"15","key":"93695_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306229","volume":"11","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Splicing factor pqbp1 curtails bax expression to promote ovarian cancer progression. Adv. Sci. (Weinh) 11(15), e2306229 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"20","key":"93695_CR47","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1111\/jcmm.17540","volume":"26","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Snora70e promotes the occurrence and development of ovarian cancer through pseudouridylation modification of rap1b and alternative splicing of parpbp. J. Cell Mol. Med. 26(20), 5150 (2022).","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"93695_CR48","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/ijc.32331","volume":"145","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. U2-related proteins cherp and sr140 contribute to colorectal tumorigenesis via alternative splicing regulation. Int. J. Cancer 145(10), 2728 (2019).","journal-title":"Int. J. Cancer"},{"issue":"12","key":"93695_CR49","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1261\/rna.078935.121","volume":"27","author":"E Mart\u00edn","year":"2021","unstructured":"Mart\u00edn, E. et al. Alternative splicing regulation of cell-cycle genes by spf45\/sr140\/cherp complex controls cell proliferation. RNA 27(12), 1557 (2021).","journal-title":"RNA"},{"issue":"3","key":"93695_CR50","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/med.21765","volume":"41","author":"H Sadeghi Rad","year":"2021","unstructured":"Sadeghi Rad, H. et al. Understanding the tumor microenvironment for effective immunotherapy. Med. Res. Rev. 41(3), 1474 (2021).","journal-title":"Med. Res. Rev."},{"key":"93695_CR51","doi-asserted-by":"publisher","first-page":"28208","DOI":"10.1038\/srep28208","volume":"6","author":"HH Nguyen","year":"2016","unstructured":"Nguyen, H. H. et al. Na\u00efve cd8(+) t cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-\u03b2 immunosuppression in the tumor microenvironment. Sci. Rep. 6, 28208 (2016).","journal-title":"Sci. Rep."},{"key":"93695_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107151","volume":"163","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between m0 macrophages and na\u00efve cd4(+) t cells in the immunosuppressive microenvironment of cervical cancer. Comput. Biol. Med. 163, 107151 (2023).","journal-title":"Comput. Biol. Med."},{"issue":"12","key":"93695_CR53","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2217\/imt.14.90","volume":"6","author":"CL Schwab","year":"2014","unstructured":"Schwab, C. L. et al. Past, present and future targets for immunotherapy in ovarian cancer. Immunotherapy 6(12), 1279 (2014).","journal-title":"Immunotherapy"},{"issue":"52","key":"93695_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313693120","volume":"120","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Enpp1 is an innate immune checkpoint of the anticancer cgamp-sting pathway in breast cancer. Proc. Natl. Acad. Sci. USA 120(52), e2313693120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"93695_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12943-023-01885-w","volume":"22","author":"M Yi","year":"2023","unstructured":"Yi, M. et al. Exploiting innate immunity for cancer immunotherapy. Mol. Cancer 22(1), 187 (2023).","journal-title":"Mol. Cancer"},{"issue":"8","key":"93695_CR56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrd4591","volume":"14","author":"KM Mahoney","year":"2015","unstructured":"Mahoney, K. M., Rennert, P. D. & Freeman, G. J. Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14(8), 561 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"93695_CR57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-pd-1) in melanoma. N. Engl. J. Med. 369(2), 134 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"93695_CR58","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","volume":"24","author":"TN Gide","year":"2018","unstructured":"Gide, T. N. et al. Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma. Clin. Cancer Res. 24(6), 1260 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"93695_CR59","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","volume":"41","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial cite-seq. Nat. Biotechnol. 41(10), 1405 (2023).","journal-title":"Nat. Biotechnol."},{"key":"93695_CR60","first-page":"4556","volume":"61","author":"A Baysoy","year":"2024","unstructured":"Baysoy, A. et al. Spatially resolved in vivo crispr screen sequencing via perturb-dbit. bioRxiv 61, 4556 (2024).","journal-title":"bioRxiv"},{"key":"93695_CR61","first-page":"1270","volume":"137","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping. bioRxiv 137, 1270 (2024).","journal-title":"bioRxiv"},{"issue":"D1","key":"93695_CR62","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","volume":"44","author":"M Ryan","year":"2016","unstructured":"Ryan, M. et al. Tcgaspliceseq a compendium of alternative mrna splicing in cancer. Nucleic Acids Res. 44(D1), D1018 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"93695_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/humu.21609","volume":"33","author":"F Piva","year":"2012","unstructured":"Piva, F. et al. Spliceaid 2: A database of human splicing factors expression data and RNA target motifs. Hum. Mutat. 33(1), 81 (2012).","journal-title":"Hum. Mutat."},{"issue":"1","key":"93695_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"M Seiler","year":"2018","unstructured":"Seiler, M. et al. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep. 23(1), 282 (2018).","journal-title":"Cell Rep."},{"issue":"1","key":"93695_CR65","doi-asserted-by":"publisher","first-page":"11932","DOI":"10.1038\/s41598-018-30310-2","volume":"8","author":"S Ahajjam","year":"2018","unstructured":"Ahajjam, S. & Badir, H. Identification of influential spreaders in complex networks using hybridrank algorithm. Sci. Rep. 8(1), 11932 (2018).","journal-title":"Sci. Rep."},{"issue":"1","key":"93695_CR66","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1038\/s41598-022-17468-6","volume":"12","author":"H Luan","year":"2022","unstructured":"Luan, H. et al. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma. Sci. Rep. 12(1), 13002 (2022).","journal-title":"Sci. Rep."},{"key":"93695_CR67","doi-asserted-by":"publisher","first-page":"1295831","DOI":"10.3389\/fimmu.2023.1295831","volume":"14","author":"Z Cai","year":"2023","unstructured":"Cai, Z. et al. Fanci serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma. Front. Immunol. 14, 1295831 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"93695_CR68","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. Gsca: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 24(1), 558 (2023).","journal-title":"Brief Bioinform."},{"issue":"D1","key":"93695_CR69","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. Cancersea: A cancer single-cell state atlas. Nucleic Acids Res. 47(D1), D900 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93695-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93695-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:58:20Z","timestamp":1742410700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93695-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93695-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9486"}}